Lab
Lab Genomics, LLC
Lab Genomics, LLC was paid $10.98M by Medicaid between Aug 2018 and Dec 2024, across 41 billing codes. Its largest line is 87150, — 27% of everything it billed.
33Billing provider infoLAB GENOMICS, LLC
FOUNTAIN VALLEY, CA 92708
FOUNTAIN VALLEY, CA 92708
33aNPI1225316482assigned 07/21/2011
33bProvider typeClinical Medical Laboratory
28Total paid$10.98M
24GClaims160,036
24DCodes billed41
24AFirst – last monthAug 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#68 of 561
Median peer was paid$222K
This provider vs. median50×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,110 | $9K | |
| 2019 | 16,377 | $1.18M | |
| 2020 | 30,432 | $1.79M | |
| 2021 | 36,770 | $2.35M | |
| 2022 | 39,755 | $2.74M | |
| 2023 | 17,434 | $1.37M | |
| 2024incomplete | 18,158 | $1.54M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87150 | 27% | 13,729 | 12,841 | $3.01M | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 23% | 10,357 | 8,912 | $2.48M |
| 88325 | 11% | 13,925 | 13,560 | $1.16M | |
| 81514 | 5.6% | 3,107 | 3,054 | $615K | |
| 87481 | 3.5% | 8,910 | 8,003 | $388K | |
| 87640 | 3.3% | 12,931 | 11,974 | $365K | |
| 87500 | 3.2% | 14,218 | 13,196 | $350K | |
| 87653 | 3.1% | 7,734 | 7,395 | $342K | |
| 87556 | 3.0% | 11,295 | 10,736 | $324K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.5% | 10,777 | 10,256 | $278K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.5% | 10,646 | 10,129 | $276K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2.3% | 2,203 | 2,193 | $247K |
29 more codes
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.0% | 652 | $223K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.5% | 6,831 | $163K |
| 87800 | 1.2% | 3,274 | $136K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.2% | 4,862 | $132K |
| 84630 | 1.1% | 3,351 | $126K | |
| 87631 | <1% | 2,731 | $72K | |
| 87581 | <1% | 3,361 | $60K | |
| 87486 | <1% | 3,232 | $57K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,260 | $39K |
| 87498 | <1% | 2,245 | $38K | |
| 87186 | <1% | 517 | $31K | |
| 87532 | <1% | 1,818 | $25K | |
| 87530 | <1% | 644 | $14K | |
| 86635 | <1% | 2,283 | $13K | |
| 87496 | <1% | 644 | $11K | |
| 87482 | <1% | 274 | $4K | |
| 81105 | <1% | 41 | $2K | |
| 81401 | <1% | 78 | $1K | |
| 81479 | Unlisted molecular pathology procedure | <1% | 63 | $682.18 |
| 81001 | <1% | 87 | $227.04 | |
| 81335 | <1% | 112 | $162.96 | |
| 0099U | <1% | 503 | $154.59 | |
| 81231 | <1% | 49 | $46.00 | |
| 81230 | <1% | 49 | $45.00 | |
| 81225 | <1% | 32 | $40.29 | |
| 81328 | <1% | 49 | $40.00 | |
| 81400 | <1% | 112 | $24.93 | |
| 81226 | 0% | 32 | $0.00 | |
| 87506 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMANAKTALA, SUSHAM (EXECUTIVE ADMINISTRATION)